Paragraph 35 Traditional herbal registrations
Subject to sub-paragraphs (3) to (6), the fee payable under regulation 12(1)(a) in connection with an application for a traditional herbal registration of a kind described in column 1 of the following table is the fee specified in the corresponding entry in column 2 of that table.
Fee for application for traditional herbal registration
| Column 1 | Column 2 | |||
|---|---|---|---|---|
| Kind of application | Fee payable | |||
| 1. Complex registration application | ||||
| (a) | in respect of a medicinal product containing a single active ingredient | F1£5,899 | ||
| (b) | in any other case | F2£8,848 | ||
| 2. Standard registration application | ||||
| (a) | in respect of a medicinal product containing 3 or fewer active ingredients | F3£2,950 | ||
| (b) | in any other case | F4£4,424 | ||
| 3. Reduced registration application category II | ||||
| (a) | in respect of a medicinal product containing 3 or fewer active ingredients | F5£983 | ||
| (b) | in any other case | F6£1,476 | ||
| 4. Reduced registration application category I | ||||
| (a) | in respect of a medicinal product containing 3 or fewer active ingredients | F7£657 | ||
| (b) | in any other case | F8£983 | ||
| 5. Change of ownership application | F9£592 | |||
Each reference in sub-paragraphs (3) to (6) to an amount payable under sub-paragraph (1) in respect of an application refers to the amount payable under that sub-paragraph in respect of an application of the kind in question.
Where an application relates to a medicinal product which contains one or more vitamins or minerals which are vitamins or minerals from a new source, a fee of—
F10£1,311, if European Pharmacopoeia certificates of suitability covering all the vitamins or minerals which are a vitamin or mineral from a new source have been submitted with the application; or
F11£2,622, in any other case,
is payable in addition to the amount payable under sub-paragraph (1) in respect of that application.
Where an application relates to a medicinal product which contains one or more new excipients, an amount of F12£8,748 is payable in addition to the amount payable under sub-paragraph (1) in respect of that application.
Where an application relates to a medicinal product which contains one or more TSE risk excipients from a new source, an amount of F13£777 is payable in addition to the amount payable under sub-paragraph (1) in respect of that application.
Where an application relates to a medicinal product which is a sterile medicinal product, an amount of F14£2,622 is payable in addition to the amount payable under sub-paragraph (1) in respect of that application.
Annotations
Textual amendments
- F1
Sum in Sch. 2 para. 35(1) Table Entry 1(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(i)(aa)
- F2
Sum in Sch. 2 para. 35(1) Table Entry 1(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(i)(bb)
- F3
Sum in Sch. 2 para. 35(1) Table Entry 2(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(ii)(aa)
- F4
Sum in Sch. 2 para. 35(1) Table Entry 2(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(ii)(bb)
- F5
Sum in Sch. 2 para. 35(1) Table Entry 3(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(iii)(aa)
- F6
Sum in Sch. 2 para. 35(1) Table Entry 3(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(iii)(bb)
- F7
Sum in Sch. 2 para. 35(1) Table Entry 4(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(iv)(aa)
- F8
Sum in Sch. 2 para. 35(1) Table Entry 4(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(iv)(bb)
- F9
Sum in Sch. 2 para. 35(1) Table Entry 5 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(v)
- F10
Sum in Sch. 2 para. 35(3)(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(b)(i)
- F11
Sum in Sch. 2 para. 35(3)(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(b)(ii)
- F12
Sum in Sch. 2 para. 35(4) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(c)
- F13
Sum in Sch. 2 para. 35(5) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(d)
- F14
Sum in Sch. 2 para. 35(6) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(e)